Formulation and Evaluation of Mouth Dissolving Tablets of Piroxicam



  • Sudarshan Singh
  • S S Shyale
  • G Bhosale


Piroxicam, a non-steroidal anti-inflammatory agent, is widely used in rheumatoid arthritis, osteoarthritis, musculo-skeletal disorders, dysmenorrhoeal and post-operative pain. It has poor bioavailability due to its inherent properties. The objective of present study is to enhance water solubility of Piroxicam by solid dispersion technique and to develop novel method of preparing compressed tablets for Piroxicam with high porosity which dissolves rapidly in mouth, using camphor as sublimating agent and super disintegrants such as Crosscarmellose sodium and sodium starch glycollate. The tablets were evaluated for hardness, thickness, friability, weight variation, wetting time, disintegration time, drug content and in vitro drug release. Optimized formulation was evaluated for stability according to ICH guideline. All tablets had hardness in range of 2.8-3.1 kg/cm2 and friability of all formulations was less than 1.0%. Weight variation and drug content were within USP limits. A stability study for optimized F6 formulation 40 °C / 75 % RH for 30 days showed little change in drug content. Therefore, it is concluded that enhance solubility and increased levels of the super disintegrants Cross carmellose sodium and sodium starch glycollate increases the rate of Piroxicam release. Camphor decreases disintegration time of tablets and create high porosity which dissolve rapidly in mouth and could be industrially feasible.


Download data is not yet available.


Metrics Loading ...


Piroxicam, β-Cyclodextrin, Crosscarmellose Sodium, Sodium Starch Glycollate




How to Cite

Singh S, Shyale SS, Bhosale G. Formulation and Evaluation of Mouth Dissolving Tablets of Piroxicam. Scopus Indexed [Internet]. 2015 Aug. 30 [cited 2024 Jun. 14];8(3):2941-6. Available from:



Research Articles


Ashish P, Harsoliya MS, Pathan JK and Shruti S (2011). A Review Formulation of Mouth Dissolving tablet. Int J Pharm Clinic Sci, 1(1): 1-8.

Bhowmik D, Chiranjib B, Krishnakanth, Pankaj, Chandira R M (2009). Fast Dissolving Tablet: An overview. J Chem and Pharm Res, 1(1): 163-177.

Jens TC and Rhodes C T (2009). Drug Stability Principle and Practice. Third edition, Volume 107 Marcel Deccker Series, pp-104-11.

Lachman L and Liberman HA (2009). The Theory and Practice of Industrial Pharmacy. 3rd edition. pp-183-193.

Patrick M and Sinko J (2009). Physical Pharmacy and Pharma-ceutical science. B.I. Publication Pvt. Ltd, 5th edition, pp-232.

Prajapati BG and Ratnakar N (2009). A Review on recent Patents on Fast Dissolving Drug Delivery System. Int J Pharm Tech Res, 1(3): 790-798.

Radha M, Kanaka DD and Prameela R (2010). Preparation and Characterization of Zafirlukast β-Cyclodextrin Complexes using Solid Dispersion Techniques. Int J Pharm Sci Res, 4(1): 88-93.

Singh SK, Borkhataria CH, Seth NR, Patel RP, Singh S, and Parmar G (2009). Formulation and in vitro Evaluation of Lansoprazole Micro pellets. Int J Pharm Tech Res, 1(4): 1530-1540.

Subrahmanyam CVS (2000). Text Book of Physical Pharmaceutics, 2nd edition. pp- 51-84.

Widjaja B and Setyawan D (2013). Development of Piroxicam Orally Disintegrating Tablets by Freeze Drying Method. Int J Pharm Pharm Sci, 5: 795-798.

Most read articles by the same author(s)

1 2 > >>